ArticleAdvanced functional materials2026
Controlling 3D Contractility via Engineered Fibrous Hydrogel Composites.
Article in Advanced functional materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Complex and dynamic mechanobiological crosstalk occurs between cells and their extracellular matrix (ECM) to support contraction, a process required for tissue morphogenesis and wound healing. In vitro models can be used to study this crosstalk by mimicking the ECM (collagen fibers within a ground substance) using controlled environments and defined mechanics. While useful, most in vitro models utilize poorly-defined natural hydrogels that lack independent control over hydrogel properties and contraction tunability. Here, a fully-defined hydrogel composite is introduced consisting of fragmented synthetic fibers (a collagen fiber mimic) that, when embedded within a synthetic hydrogel (a ground substance mimic), supports cell-mediated traction-based contraction in a manner similar to traditional collagen gels. Tuning this composite material by modulating fragmented fiber density and length and embedding hydrogel density and crosslinking enables control over contraction. Cells cultured within contraction-permissive constructs support microtissue cell alignment and local densification of fiber fragments, while culture in contraction-resistant composites (greater embedding hydrogel crosslinking) do not. This innovative composite material expands our ability to interrogate the complex cell-ECM interplay during tissue morphogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.